DK0751782T3 - Anvendelse af et ikke-neutraliserende antistof, som er specifikt for beta-subunit'en i luteiniserende hormon, til forbedring af fertilitet - Google Patents
Anvendelse af et ikke-neutraliserende antistof, som er specifikt for beta-subunit'en i luteiniserende hormon, til forbedring af fertilitetInfo
- Publication number
- DK0751782T3 DK0751782T3 DK95911043T DK95911043T DK0751782T3 DK 0751782 T3 DK0751782 T3 DK 0751782T3 DK 95911043 T DK95911043 T DK 95911043T DK 95911043 T DK95911043 T DK 95911043T DK 0751782 T3 DK0751782 T3 DK 0751782T3
- Authority
- DK
- Denmark
- Prior art keywords
- present
- stimulating
- luteinizing hormone
- fertility
- activity
- Prior art date
Links
- 102000009151 Luteinizing Hormone Human genes 0.000 title abstract 4
- 108010073521 Luteinizing Hormone Proteins 0.000 title abstract 4
- 230000035558 fertility Effects 0.000 title abstract 4
- 229940040129 luteinizing hormone Drugs 0.000 title abstract 3
- 230000003472 neutralizing effect Effects 0.000 title 1
- 230000000694 effects Effects 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 230000004936 stimulating effect Effects 0.000 abstract 3
- 102000011022 Chorionic Gonadotropin Human genes 0.000 abstract 2
- 108010062540 Chorionic Gonadotropin Proteins 0.000 abstract 2
- 102000003886 Glycoproteins Human genes 0.000 abstract 2
- 108090000288 Glycoproteins Proteins 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 2
- 239000011230 binding agent Substances 0.000 abstract 2
- 230000004071 biological effect Effects 0.000 abstract 2
- 229940088597 hormone Drugs 0.000 abstract 2
- 239000005556 hormone Substances 0.000 abstract 2
- 229940084986 human chorionic gonadotropin Drugs 0.000 abstract 2
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 abstract 1
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 abstract 1
- 102000006771 Gonadotropins Human genes 0.000 abstract 1
- 108010086677 Gonadotropins Proteins 0.000 abstract 1
- 206010033266 Ovarian Hyperstimulation Syndrome Diseases 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 229940028334 follicle stimulating hormone Drugs 0.000 abstract 1
- 239000002622 gonadotropin Substances 0.000 abstract 1
- 239000003933 gonadotropin antagonist Substances 0.000 abstract 1
- 229940094892 gonadotropins Drugs 0.000 abstract 1
- 230000003054 hormonal effect Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Reproductive Health (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Gynecology & Obstetrics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pregnancy & Childbirth (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Control Of Eletrric Generators (AREA)
- Beans For Foods Or Fodder (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19938294A | 1994-02-18 | 1994-02-18 | |
PCT/US1995/002067 WO1995022340A1 (fr) | 1994-02-18 | 1995-02-17 | Procedes de modification de la fecondite |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0751782T3 true DK0751782T3 (da) | 2007-01-29 |
Family
ID=22737277
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95911043T DK0751782T3 (da) | 1994-02-18 | 1995-02-17 | Anvendelse af et ikke-neutraliserende antistof, som er specifikt for beta-subunit'en i luteiniserende hormon, til forbedring af fertilitet |
Country Status (11)
Country | Link |
---|---|
US (2) | US7001597B1 (fr) |
EP (3) | EP0751782B1 (fr) |
JP (3) | JPH09509418A (fr) |
AT (2) | ATE314392T1 (fr) |
AU (1) | AU695111B2 (fr) |
CA (1) | CA2183564C (fr) |
DE (2) | DE69534723T2 (fr) |
DK (1) | DK0751782T3 (fr) |
ES (2) | ES2273335T3 (fr) |
PT (1) | PT751782E (fr) |
WO (1) | WO1995022340A1 (fr) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0910648A1 (fr) * | 1996-04-15 | 1999-04-28 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions solubles de recepteurs couples a des proteine g du domaine transmembranaire 7 et leurs procedes de fabrication |
WO1998021238A1 (fr) * | 1996-11-12 | 1998-05-22 | Teikoku Hormone Mfg. Co., Ltd. | Gonadotrophine chorionique equine, monocatenaire et recombinee |
ZA987497B (en) * | 1997-09-08 | 1999-02-23 | Akzo Nobel Nv | Expression of gonadotropins in dictyostelium |
US6103501A (en) * | 1997-11-17 | 2000-08-15 | Washington University | Single chain glycoprotein hormones comprising two β and one α subunits and recombinant production thereof |
US6635256B1 (en) * | 1998-10-19 | 2003-10-21 | Washington University | Glycoprotein hormone compositions comprising two β subunits and methods of use thereof |
US5981249A (en) * | 1998-02-05 | 1999-11-09 | Spectral Diagnostics, Inc. | Single-chain polypeptides comprising creatine kinase M and creatine kinase B |
EP1115866A1 (fr) * | 1998-09-22 | 2001-07-18 | University of Maryland at Baltimore | Mutants du facteur de croissance a noeud de cystine |
DE19910394A1 (de) * | 1999-03-03 | 2000-09-07 | Schering Ag | Substanzen für die Fertilitätskontrolle |
US6342411B1 (en) * | 1999-09-03 | 2002-01-29 | Motorola Inc. | Electronic component and method for manufacture |
KR20010077538A (ko) * | 2000-02-03 | 2001-08-20 | 김강권 | 단일체인 융모성성선자극호르몬 및 그 제조방법 |
JP2001333772A (ja) | 2000-04-25 | 2001-12-04 | Washington Univ | 可変性の活性を有する単鎖稔性ホルモン |
WO2001081406A2 (fr) * | 2000-04-25 | 2001-11-01 | Washington University | Hormones de fertilite a une seule chaine avec activite lh variable |
US6987172B2 (en) | 2001-03-05 | 2006-01-17 | Washington University In St. Louis | Multifunctional single chain glycoprotein hormones comprising three or more β subunits |
ES2371465T3 (es) * | 2003-09-26 | 2012-01-03 | Institut National De La Recherche Agronomique (Inra) | Anticuerpos que modulan la actividad de gonadotropina coriónica equina. |
EP3765841A4 (fr) * | 2018-03-16 | 2022-06-08 | Quest Diagnostics Investments LLC | Détermination par spectrométrie de masse de la testostérone dans des échantillons de patients multiplexés |
BR102019004147A2 (pt) | 2019-02-28 | 2020-10-06 | Ouro Fino Saude Animal Participacoes S.A. | Gonadotrofina coriônica equina recombinante (recg) biologicamente ativa e processo para obtenção da mesma, composição veterinária e uso |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4514505A (en) * | 1982-05-21 | 1985-04-30 | The Trustees Of Columbia University In The City Of New York | Monoclonal antibody mixtures and use thereof for enhanced sensitivity immunoassays |
US5284778A (en) * | 1985-08-12 | 1994-02-08 | The Trustees Of Columbia University In The City Of New York | Sensitive bioassay using monoclonal antibodies which bind to hormone-receptor complexes |
US4973577A (en) * | 1986-04-04 | 1990-11-27 | The Salk Institute For Biological Studies | FSH-releasing peptides |
US4946778A (en) * | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
WO1988009344A1 (fr) * | 1987-05-21 | 1988-12-01 | Creative Biomolecules, Inc. | Proteines mutifonctionnelles a cible predeterminee |
CA2082424C (fr) * | 1990-05-08 | 2003-09-23 | Robert K. Campbell | Analogues d'hormones glycoproteiniques presentant des caracteristiques immunologiques, une efficacite et/ou une specificite pour un recepteur alterees |
ATE193540T1 (de) * | 1991-06-18 | 2000-06-15 | Univ New Jersey Med | Analoga von glykoproteinhormonen mit geänderter rezeptorbindungsspezifität und aktivität und verfahren zur darstellung und verwendung derselben |
US5508261A (en) * | 1991-06-18 | 1996-04-16 | University Of Medicine & Dentistry Of New Jersey | Analogs of glycoprotein hormones having altered receptor binding specificity and activity and methods for preparing and using same |
AU5670194A (en) * | 1992-11-20 | 1994-06-22 | Enzon, Inc. | Linker for linked fusion polypeptides |
EP0725795B1 (fr) * | 1994-08-12 | 2004-01-14 | Washington University | Formes monocatenaires du quadruplet d'hormones de glycoproteine |
-
1995
- 1995-02-17 CA CA2183564A patent/CA2183564C/fr not_active Expired - Fee Related
- 1995-02-17 DE DE69534723T patent/DE69534723T2/de not_active Expired - Lifetime
- 1995-02-17 EP EP95911043A patent/EP0751782B1/fr not_active Expired - Lifetime
- 1995-02-17 EP EP97122148A patent/EP0839831B1/fr not_active Expired - Lifetime
- 1995-02-17 PT PT95911043T patent/PT751782E/pt unknown
- 1995-02-17 EP EP06021253A patent/EP1849802A2/fr not_active Withdrawn
- 1995-02-17 AT AT97122148T patent/ATE314392T1/de active
- 1995-02-17 AT AT95911043T patent/ATE342061T1/de active
- 1995-02-17 DE DE69535260T patent/DE69535260T2/de not_active Expired - Lifetime
- 1995-02-17 ES ES95911043T patent/ES2273335T3/es not_active Expired - Lifetime
- 1995-02-17 ES ES97122148T patent/ES2251731T3/es not_active Expired - Lifetime
- 1995-02-17 WO PCT/US1995/002067 patent/WO1995022340A1/fr active IP Right Grant
- 1995-02-17 DK DK95911043T patent/DK0751782T3/da active
- 1995-02-17 JP JP7521944A patent/JPH09509418A/ja active Pending
- 1995-02-17 AU AU18787/95A patent/AU695111B2/en not_active Ceased
-
1997
- 1997-06-02 US US08/867,587 patent/US7001597B1/en not_active Expired - Fee Related
-
1998
- 1998-10-14 JP JP10292659A patent/JPH11263799A/ja active Pending
-
2001
- 2001-06-05 JP JP2001170329A patent/JP2002060347A/ja active Pending
-
2005
- 2005-09-16 US US11/229,140 patent/US20070253955A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JPH09509418A (ja) | 1997-09-22 |
ATE342061T1 (de) | 2006-11-15 |
JPH11263799A (ja) | 1999-09-28 |
US20070253955A1 (en) | 2007-11-01 |
WO1995022340A1 (fr) | 1995-08-24 |
EP0839831A3 (fr) | 1999-09-29 |
CA2183564C (fr) | 2010-07-13 |
PT751782E (pt) | 2007-01-31 |
ATE314392T1 (de) | 2006-01-15 |
DE69535260D1 (de) | 2006-11-23 |
EP0751782B1 (fr) | 2006-10-11 |
AU1878795A (en) | 1995-09-04 |
JP2002060347A (ja) | 2002-02-26 |
EP0751782A4 (fr) | 2000-09-27 |
EP0839831A2 (fr) | 1998-05-06 |
AU695111B2 (en) | 1998-08-06 |
EP0751782A1 (fr) | 1997-01-08 |
DE69534723T2 (de) | 2006-08-31 |
DE69535260T2 (de) | 2007-08-09 |
ES2273335T3 (es) | 2007-05-01 |
EP0839831B1 (fr) | 2005-12-28 |
EP1849802A2 (fr) | 2007-10-31 |
DE69534723D1 (de) | 2006-02-02 |
US7001597B1 (en) | 2006-02-21 |
CA2183564A1 (fr) | 1995-08-24 |
ES2251731T3 (es) | 2006-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0751782T3 (da) | Anvendelse af et ikke-neutraliserende antistof, som er specifikt for beta-subunit'en i luteiniserende hormon, til forbedring af fertilitet | |
Flack et al. | Increased biological activity due to basic isoforms in recombinant human follicle-stimulating hormone produced in a human cell line | |
EP0276166A3 (fr) | Composition et méthode pour provoquer une superovulation chez le bétail | |
DE3884776T2 (de) | Durch "site-directed" Mutagenese modifzierte Glukoprotein-Hormone und Verfahren zu deren Verwendung. | |
US6414123B1 (en) | Method for purifying FSH | |
ATE115409T1 (de) | Glykoprotein-hormonrezeptor-moleküle. | |
Bernardo et al. | Adrenal luteinizing hormone releasing hormone receptors. | |
Jablonka-Shariff et al. | Expression and bioactivity of a single chain recombinant equine luteinizing hormone (reLH) | |
ATE193540T1 (de) | Analoga von glykoproteinhormonen mit geänderter rezeptorbindungsspezifität und aktivität und verfahren zur darstellung und verwendung derselben | |
Geris et al. | Influence of corticotropin-releasing factor on the in vitro thyroxine and thyrotropin secretion in newly hatched fowl | |
Xing et al. | Efficient preparation of glycoprotein hormones lacking an α-subunit oligosaccharide | |
KR900702048A (ko) | 고나도트로핀 및 그에 의한 과할성 작용제의 제조 방법 | |
Matteri et al. | Biochemical and biological properties of urinary follicle‐stimulating hormone (FSH) from the rhesus monkey (Macaca mulatta) | |
PL1518863T3 (pl) | Przeciwciała modulujące aktywność końskiej gonadotropiny kosmówkowej | |
Chaudhary et al. | Caprine (Capra hircus) luteinizing hormone: purification and chromatographic investigation of its different isoforms | |
Quesnel et al. | Solubilization and purification of the gonadotropin (GTH II) receptor from rainbow trout (Oncorhynchus mykiss) ovaries | |
Chand et al. | A reference preparation of buffalo pituitary follicle stimulating hormone using lectin affinity chromatography | |
Petrusz | Biological and immunological characterization of gonadotrophic profiles | |
Peebles et al. | Single treatment superovulation in the cashmere goat using porcine follicle stimulating hormone | |
Muralidhar | Indigenous Production of Bovine/Bubaline Reproductive Hormones | |
Schally | In vitro studies on the control of the release of ACTH. | |
Lamond | Alteration of ovarian function of immature mice treated with androgen after birth | |
Chan et al. | Binding inhibition by monoclonal antibodies of ovine placental lactogen to growth hormone receptors in human liver | |
CA2219948A1 (fr) | Chaine unique de gonadotrophines, adn les codant et methode de production | |
Bettendorf | Donini, Pietro |